What Is Elon Musk's I.Q.?
By Amanda Hess,
The New York Times
| 04. 05. 2025
Image "Elon Musk" by Debbie Rowe on Wikimedia Commons licensed under CC by S.A. 3.0
For months, an internet-wide guessing game has swirled around the question of where Elon Musk’s intelligence falls on the bell curve. President Trump has called Musk a “seriously high I.Q. individual.” Musk’s onetime biographer Seth Abramson wrote on X that he would “peg his I.Q. as between 100 and 110,” and claimed that there was “zero evidence in his biography for anything higher.” The economics commentator Noah Smith estimated Musk’s I.Q. at more than 130, a number gleaned from his reported SAT score. A circulating screenshot shows Fox News has pegged the number at 155, citing Sociosite, a junk website. The pollster Nate Silver guessed that Musk is “probably even a ‘genius,’” and theorized that he may not always appear that way because, as he put it on X, “high I.Q.s serve as a force multiplier for both positive and negative traits.”
When we speculate about Musk’s I.Q., what are we really talking about?
Not his score on an intelligence test; if he has ever...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...